Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
BACKGROUND: Tuberculosis-diabetes co-morbidity (TB-DM) is characterized by increased inflammation with elevated circulating levels of inflammatory cytokines and other factors. Circulating angiogenic factors are intricately involved in the angiogenesis-inf..... Read More